文献速递心脏核医学骨显像与常规 SPECT

骨显像在心脏淀粉样变性中的预后价值:系统综述与荟萃分析

Prognostic Value of Bone Scintigraphy in Cardiac Amyloidosis: A Systematic Review and Meta-analysis.
PubMed 文献 · Clin Nucl Med · 2024-08-01

该系统综述与荟萃分析检索截至2023年11月的文献,纳入14项研究共3325例已知或疑似心脏淀粉样变性患者,评估骨显像心脏摄取与死亡率的关联。视觉分级在任一阈值下均无预后意义,而半定量测量高心脏摄取与死亡率升高相关,合并HR为2.27(95%CI 1.87-2.76)。

要点

  • 视觉分级≥1、≥2、≥3的合并HR分别为2.25、1.55、1.53,95%CI均跨1,无预后意义。
  • 半定量测量高心脏摄取与死亡率升高相关,合并HR为2.27(95%CI 1.87-2.76)。
  • 主动脉瓣狭窄相关心脏淀粉样变性中,高心脏摄取不预测死亡率(合并HR 1.13,95%CI 0.96-1.32)。

核心结论

  • 在已知或疑似心脏淀粉样变性患者中,骨显像半定量高心脏摄取与死亡率风险升高相关。

研究设计与样本

  • 系统综述与荟萃分析,检索PubMed、Embase和Cochrane图书馆数据库截至2023年11月。
  • 最终纳入14项研究,共3325例患者。

主要发现

  • 视觉分级≥1、≥2、≥3的合并HR分别为2.25(95%CI 0.93-5.48)、1.55(95%CI 0.89-2.68)、1.53(95%CI 0.95-2.47),均无预后意义。
  • 半定量测量(心脏与对侧肺比值n=6,心脏与全身比值n=1)高心脏摄取与死亡率升高相关,所有半定量测量合并HR=2.27(95%CI 1.87-2.76)。
  • 仅心脏与对侧肺比值的合并HR=2.26(95%CI 1.86-2.74)。
  • 3种不同的99mTc放射性示踪剂之间预后意义无差异(P=0.619)。
  • 主动脉瓣狭窄相关心脏淀粉样变性中,高心脏摄取不预测死亡率(合并HR=1.13,95%CI 0.96-1.32)。

关键数值与推荐

  • 视觉分级≥1的合并HR为2.25(95%CI 0.93-5.48)。
  • 视觉分级≥2的合并HR为1.55(95%CI 0.89-2.68)。
  • 视觉分级≥3的合并HR为1.53(95%CI 0.95-2.47)。
  • 所有半定量测量高心脏摄取的合并HR为2.27(95%CI 1.87-2.76)。
  • 心脏与对侧肺比值高摄取的合并HR为2.26(95%CI 1.86-2.74)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: The prognostic value of bone scintigraphy in cardiac amyloidosis (CA) remains undetermined. We conducted a systematic review and meta-analysis on the association of cardiac uptake on bone scintigraphy with mortality in known or suspected CA. PATIENTS AND METHODS: PubMed, Embase, and Cochrane library databases were searched up to November 2023 for studies that evaluated cardiac uptake on bone scintigraphy as a prognostic factor in the workup of CA. Hazards ratios (HRs) of high cardiac uptake for outcomes of all-cause or cardiac death were pooled and analyzed with stratifications according to the study populations, analytical methodologies, and radiotracers. RESULTS: Fourteen studies (3325 patients) were finally included. In studies regarding known or suspected CA, visual grades were not prognostically significant, regardless of the threshold used, with pooled HRs of 2.25 (95% confidence interval [CI], 0.93-5.48), 1.55 (95% CI, 0.89-2.68), and 1.53 (95% CI, 0.95-2.47) for visual grades ≥1, ≥2, and ≥3, respectively. By contrast, high cardiac uptake on semiquantitative measurements (heart-to-contralateral lung ratio, n = 6; heart-to-whole-body ratio, n = 1) was associated with increased mortality (pooled HR = 2.27 [95% CI, 1.87-2.76] for all semiquantitative measurements; 2.26 [1.86-2.74] for heart-to-contralateral lung ratio only). No difference in prognostic significance was found across 3 different 99m Tc-radiotracers ( P = 0.619). However, high cardiac uptake was not predictive of mortality in aortic stenosis-related CA (pooled HR = 1.13 [95% CI, 0.96-1.32]). CONCLUSIONS: High semiquantitative cardiac uptake on bone scintigraphy is associated with an increased risk of mortality in patients with known or suspected CA.

来源:Clin Nucl Med,查看原文。版权归原作者所有。

引用

  1. Cho SG, Han S. Prognostic Value of Bone Scintigraphy in Cardiac Amyloidosis: A Systematic Review and Meta-analysis. Clin Nucl Med. 2024. PMID: 39086069. doi:10.1097/RLU.0000000000005376

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。